Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Latest Alonso Krangle LLP Stories

2014-04-15 23:09:37

Plaintiffs Seek Transfer of all Federal AndroGel Lawsuits to U.S. District Court, Northern District of Illinois, For Coordinated Pretrial Proceedings New York, NY (PRWEB) April 15, 2014 Alonso Krangle LLP, an experienced defective drug injury law firm, reports that plaintiffs who have filed AndroGel testosterone lawsuits alleging the low testosterone therapy caused men to suffer heart attacks, strokes and other serious heart problems are seeking the transfer of all federally-filed cases...

2014-04-01 23:27:44

Complaint Alleges Defendants Failed to Warn the Decedent that the Use of Morcellator During Her Hysterectomy Could Result in Seeding of Undiagnosed Sarcoma Through the Peritoneal Cavity New York, NY (PRWEB) April 01, 2014 The widow of a Pennsylvania woman who died from metastatic myleosarcoma has filed a morcellation cancer lawsuit alleging that her death was the result of uterine morcellation. According to the complaint, the use of a morcellator, a device used to remove tissue during...

2014-03-18 23:23:59

The United States Judicial Panel (USJP) on Multidistrict Litigation (MDL) has recently issued a transfer order that will remit 56 Lipitor lawsuits and many more tag-along actions to the District of South Carolina to facilitate this litigation. New York, NY (PRWEB) March 18, 2014 The attorneys at Alonso Krangle applaud the USJP’s recent transfer order that will consolidate many pending Lipitor lawsuits in an MDL that will take place in the District of South Carolina federal court (Case...

2014-02-26 23:35:02

Public Citizen’s Call for Testosterone Heart Attack Warnings Follows Launch of FDA Investigation into Low T Heart Risks, Filing of Several AndroGel Lawsuits. New York, NY (PRWEB) February 26, 2014 Alonso Krangle LLP, an experienced law firm investigating testosterone treatment lawsuits involving AndroGel and other prescription low testosterone, or Low T, therapies, commends the consumer advocacy group, Public Citizen, on its petition calling for new heart attack warnings on this class...

2014-02-11 23:26:01

Judge Gives Preliminary Approval of $100 Million To Resolve Thousands of NuvaRing Lawsuits if 95 Percent of Women Agree to Participate New York, NY (PRWEB) February 11, 2014 The lawyers at Alonso Krangle LLP, who are currently representing numerous women in NuvaRing lawsuits, are anticipating Merck, the makers of the NuvaRing contraceptive, will payout out $100 million to settle over 3,800 NuvaRing lawsuits pending in state and federal courts in New Jersey and Missouri (In re: NuvaRing...

2014-02-10 23:01:16

FDA Launches Safety Study of Prescription Testosterone Therapy Drugs after Studies Link Testosterone Treatment to Heart Attacks, Strokes and Death New York, NY (PRWEB) February 10, 2014 Alonso Krangle LLP, an experienced defective drug injury law firm, is now evaluating testosterone therapy lawsuits on behalf of men who suffered heart attacks, strokes and other life-threatening cardiovascular events, allegedly due to their use of AndroGel and other prescription testosterone treatments....

2013-11-14 23:25:40

A recently filed NuvaRing blood clot lawsuit brings attention to the alleged dangers and risks associated with the NuvaRing vaginal birth control device, including blood clots, deep vein thrombosis, and pulmonary embolism, Alonso Krangle LLP reports. New York, NY (PRWEB) November 14, 2013 A NuvaRing blood clot lawsuit was filed by Alonso Krangle LLP on behalf of a 31-year-old NuvaRing user who allegedly suffered right leg deep vein thrombosis due to side effects of the birth control...

2013-11-07 23:21:07

Proposed Novarel and Flexees Class Action Lawsuit Alleges that Wacoal America Inc. and Maidenform Brands, Inc. Falsely Marketed the Purported Slimming Properties of the Novarel Slim Fabric Used in “Novarel Slim iPant” and “Flexees” Brand Shapewear. New York, NY (PRWEB) November 07, 2013 Alonso Krangle LLP, a deiciated law firm that "fights for victims", together with its co-counsel, has filed a federal class action lawsuit against Wacoal America Inc. and Maidenform...

2013-11-05 23:26:47

The Agreement Settles Charges that Johnson & Johnson Illegally Marketed Risperdal, Invega and Natracor for Off-Label Use and Paid Kick-Backs to Physicians to Drive Sales of Risperdal and Invega, Alonso Krangle LLP reports. New York, NY (PRWEB) November 05, 2013 Johnson & Johnson has agreed to pay $2.2 billion to settle charges with the U.S. Department of Justice (DOJ) over the alleged illegal marketing of Risperdal, Invega and Natrecor, Alonso Krangle LLP reports. In a press...

2013-09-08 23:00:05

A NuvaRing pulmonary embolism lawsuit recently filed by Alonso Krangle alleges that the plaintiff’s use of NuvaRing caused her to develop a pulmonary embolism. This case also contends that Organon, the manufacturer of NuvaRing, knew about the significant risk of serious NuvaRing side effects and, yet, did not alert the public about these risks. New York, NY (PRWEB) September 08, 2013 Alonso Krangle’s attorneys have recently filed a NuvaRing pulmonary embolism lawsuit on behalf of a...